EP0404136A3 - 3,5,6-Substituierte Derivate von 1,2-0-Isopropyliden-alpha,D-glucofuranose und Zwischenprodukte zur Herstellung dieser Derivate - Google Patents

3,5,6-Substituierte Derivate von 1,2-0-Isopropyliden-alpha,D-glucofuranose und Zwischenprodukte zur Herstellung dieser Derivate Download PDF

Info

Publication number
EP0404136A3
EP0404136A3 EP19900111705 EP90111705A EP0404136A3 EP 0404136 A3 EP0404136 A3 EP 0404136A3 EP 19900111705 EP19900111705 EP 19900111705 EP 90111705 A EP90111705 A EP 90111705A EP 0404136 A3 EP0404136 A3 EP 0404136A3
Authority
EP
European Patent Office
Prior art keywords
derivatives
glucofuranose
isopropylidene
intermediates
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900111705
Other languages
English (en)
French (fr)
Other versions
EP0404136A2 (de
Inventor
Bruce Rosen
Sudershan K. Arora
Alvert V. Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alseres Pharmaceuticals Inc
Original Assignee
Greenwich Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenwich Pharmaceuticals Inc filed Critical Greenwich Pharmaceuticals Inc
Publication of EP0404136A2 publication Critical patent/EP0404136A2/de
Publication of EP0404136A3 publication Critical patent/EP0404136A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EP19900111705 1989-06-22 1990-06-20 3,5,6-Substituierte Derivate von 1,2-0-Isopropyliden-alpha,D-glucofuranose und Zwischenprodukte zur Herstellung dieser Derivate Withdrawn EP0404136A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US369932 1989-06-22
US07/369,932 US5010058A (en) 1989-06-22 1989-06-22 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives

Publications (2)

Publication Number Publication Date
EP0404136A2 EP0404136A2 (de) 1990-12-27
EP0404136A3 true EP0404136A3 (de) 1992-07-22

Family

ID=23457536

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900111705 Withdrawn EP0404136A3 (de) 1989-06-22 1990-06-20 3,5,6-Substituierte Derivate von 1,2-0-Isopropyliden-alpha,D-glucofuranose und Zwischenprodukte zur Herstellung dieser Derivate

Country Status (10)

Country Link
US (1) US5010058A (de)
EP (1) EP0404136A3 (de)
JP (1) JPH03163091A (de)
KR (1) KR910000772A (de)
AU (1) AU5769190A (de)
CA (1) CA2019705A1 (de)
IE (1) IE902221A1 (de)
IL (1) IL94821A0 (de)
NO (1) NO902750L (de)
ZA (1) ZA904783B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298494A (en) * 1989-01-09 1994-03-29 Greenwich Pharmaceuticals Incorporated Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
IE913228A1 (en) * 1990-09-12 1992-02-25 Greenwich Pharmaceuticals Monosaccharides having anti-proliferation and¹anti-inflammatory activity, compositions and uses thereof
IL100833A0 (en) * 1991-02-20 1992-09-06 Greenwich Pharma Method for synthesis of ethereally substituted blocked monosaccharides
US5360792A (en) * 1991-12-20 1994-11-01 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom
FR2694753B1 (fr) * 1992-07-09 1994-12-23 Picardie Jules Verne Universit Procédés de synthèse spécifique de nouveaux aminothioéthers par substitution des sites hydroxylés sur des molécules mono ou polyhydroxylées, produits obtenus par ces procédés et leurs applications.
US5360794A (en) * 1992-08-03 1994-11-01 Medicarb Inc. Disubstituted and deoxy disubstituted derivatives of α-D-mannofuranosides and β-L-gulofuranosides having anti-inflammatory and anti-proliferative activity
US5367062A (en) * 1992-08-21 1994-11-22 Medicarb Inc. Disubstituted and deoxydisubstituted derivatives of α-d-lyxofuranosides having anti-inflammatory and anti-proliferative activity
US5432163A (en) * 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
AU7101994A (en) * 1993-06-11 1995-01-03 Boston Life Sciences, Inc. Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
US6329344B1 (en) 1998-10-22 2001-12-11 Ranbaxy Laboratories Limited Derivatives of monosaccharides as cell adhesion inhibitors
IN190975B (de) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
WO2002098419A1 (en) * 2001-06-05 2002-12-12 Kinetek Pharmaceuticals, Inc. Integrin linked kinase modulation of macrophage activation
WO2005092907A2 (en) * 2004-03-26 2005-10-06 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
EP1789428A1 (de) * 2004-09-02 2007-05-30 Ranbaxy Laboratories Limited Monosaccharidderivate
EP1902063A2 (de) * 2004-12-22 2008-03-26 Ranbaxy Laboratories Limited Derivate von pentosemonosacchariden als entzündungshemmende verbindungen
US20090048186A1 (en) * 2005-04-19 2009-02-19 Vishwajanani Jitendra Sattigeri Monosaccharide Derivatives as Anti-Inflammatory and/or Anti-Cancer Agents
EP1842855A3 (de) * 2006-03-29 2007-12-05 Ranbaxy Laboratories Limited Monosaccharidderivate als Entzündungshemmende und/oder Anti-Tumor Agentien
EP1864992A2 (de) * 2006-05-30 2007-12-12 Ranbaxy Laboratories, Ltd. Monosaccharidderivate
EP1953170A1 (de) * 2006-10-03 2008-08-06 Ranbaxy Laboratories Limited Monosaccharidderivate als entzündungshemmende Agentien
CN104530148A (zh) * 2014-12-09 2015-04-22 济南卡博唐生物科技有限公司 一种制备3,5,6-三-氧-苄基-1,2-异丙叉基-d-葡萄糖的改进方法
CN104387428A (zh) * 2014-12-09 2015-03-04 济南卡博唐生物科技有限公司 一种制备3,5,6-三-氧-苄基-1,2-异丙叉基-d-葡萄糖的方法
CN104478955A (zh) * 2014-12-09 2015-04-01 济南卡博唐生物科技有限公司 一种3,5,6-三-氧-苄基-1,2-异丙叉基-d-葡萄糖的制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2219782A1 (de) * 1973-03-01 1974-09-27 Strategic Medical Res Corp
FR2254348A2 (de) * 1973-12-14 1975-07-11 Strategic Medical Res Corp
FR2370753A1 (fr) * 1976-11-16 1978-06-09 Bruzzese Tiberio Derives du glucofurannose et leur application therapeutique
US4735934A (en) * 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
FR2614024A1 (fr) * 1987-04-14 1988-10-21 Generale Sucriere Sa Procede de synthese specifique de o-alkyl-3 d-glucose et produits obtenus par ce procede
EP0379397A2 (de) * 1989-01-09 1990-07-25 Greenwich Pharmaceuticals Incorporated Alpha-D-Glukofuranose-Derivate und Zwischenprodukte zur Herstellung davon

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2461478A (en) * 1946-12-18 1949-02-08 Gen Aniline & Film Corp Gelatin subbing compositions having antistatic properties
US2875194A (en) * 1955-10-05 1959-02-24 American Cyanamid Co Derivatives of 5-amino-d-ribofuranose
US2960452A (en) * 1958-07-14 1960-11-15 Miles Lab Preparation of diacetone 2-keto-gulonic acid
US3586664A (en) * 1969-03-19 1971-06-22 Eisai Co Ltd Xylose derivatives and preparation thereof
US3832355A (en) * 1970-05-13 1974-08-27 Hoffmann La Roche Catalytic oxidation process
US4032650A (en) * 1972-09-15 1977-06-28 A.E.C. Societe De Chimie Organique Et Biologique Method of treating fatigue by administering a gulonic acid salt
USRE30379E (en) * 1973-03-01 1980-08-19 Strategic Medical Research Corp. Ethereal monosubstitutions of monosaccharide derivatives
US3939146A (en) * 1973-03-01 1976-02-17 Strategic Medical Research Corporation Novel ethereal monosubstitutions of monosaccharide derivatives
USRE32268E (en) * 1973-03-01 1986-10-21 Strategic Medical Research Corp. Therapeutic composition and method of therapeutically treating warm blooded animals therewith
US3965262A (en) * 1973-03-01 1976-06-22 Strategic Medical Research Corporation Method of enhancing learning and/or memory in warm blooded animals
US4016261A (en) * 1973-03-01 1977-04-05 Strategic Medical Research Corporation Therapeutic composition and method of therapeutically treating warm blooded animals therewith
US4017608A (en) * 1973-12-14 1977-04-12 Strategic Medical Research Corporation Therapeutic composition and method of therapeutically treating warm blooded animals therewith
US4056322A (en) * 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4010275A (en) * 1975-03-18 1977-03-01 Ciba-Geigy Corporation Treatment of osteoarthritis
USRE30354E (en) * 1978-02-17 1980-07-29 Strategic Medical Research Corp. Novel ethereally monosubstituted monosaccharides
DE2830469A1 (de) * 1978-07-11 1980-01-24 Bayer Ag Herstellung von l-desoxy-nojirimycin und n-substituierten derivaten
US4738953A (en) * 1981-02-17 1988-04-19 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease and a synergistic composition therefor
US4554349A (en) * 1983-10-11 1985-11-19 Merck & Co., Inc. Aralkyl and aralkenyl glycosides as inhibitors of antigen-specific T-cell proliferation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2219782A1 (de) * 1973-03-01 1974-09-27 Strategic Medical Res Corp
FR2254348A2 (de) * 1973-12-14 1975-07-11 Strategic Medical Res Corp
AU533108B2 (en) * 1973-12-14 1983-11-03 Strategic Medical Research Corp. Etherfied monosaccharides
FR2370753A1 (fr) * 1976-11-16 1978-06-09 Bruzzese Tiberio Derives du glucofurannose et leur application therapeutique
US4735934A (en) * 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
FR2614024A1 (fr) * 1987-04-14 1988-10-21 Generale Sucriere Sa Procede de synthese specifique de o-alkyl-3 d-glucose et produits obtenus par ce procede
EP0379397A2 (de) * 1989-01-09 1990-07-25 Greenwich Pharmaceuticals Incorporated Alpha-D-Glukofuranose-Derivate und Zwischenprodukte zur Herstellung davon

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 35, no. 7, July 1987, pages 2894-2899, Tokyo, JP; T. IKEKAWA et al.: "Studies on synthesis of 3-O-alkyl-D-glucose and 3-O-alkyl-D-allose derivatives and their biological activities" *

Also Published As

Publication number Publication date
IE902221L (en) 1990-12-22
NO902750D0 (no) 1990-06-20
NO902750L (no) 1990-12-27
IL94821A0 (en) 1991-04-15
IE902221A1 (en) 1991-01-16
US5010058A (en) 1991-04-23
KR910000772A (ko) 1991-01-30
JPH03163091A (ja) 1991-07-15
EP0404136A2 (de) 1990-12-27
ZA904783B (en) 1991-03-27
AU5769190A (en) 1991-01-03
CA2019705A1 (en) 1990-12-22

Similar Documents

Publication Publication Date Title
EP0404136A3 (de) 3,5,6-Substituierte Derivate von 1,2-0-Isopropyliden-alpha,D-glucofuranose und Zwischenprodukte zur Herstellung dieser Derivate
EP0379397A3 (de) Alpha-D-Glukofuranose-Derivate und Zwischenprodukte zur Herstellung davon
AU649226B2 (en) Novel cytokines
HK143793A (en) Conductive resin structure for connecting metal conductors
DE3266096D1 (en) Arrangement for adjusting the value of an electrical component
FR2653197B1 (fr) Procede d'etancheification d'une extremite d'element de chauffage electrique et element etancheifie par ce procede.
DE3880281D1 (de) 5-nitro-4,6-bis-(3-nitro-1h-1,2,4-triazol-1-yl)pyrimidin, verfahren zu seiner herstellung und dieses enthaltender sprengstoff.
BE895784A (fr) 1,3,4-thiadiazolo (3,2-a) pyrimidines substituees utiles comme medicaments et procede de leur preparation
NO920221D0 (no) Biologisk nedbrytbar dielektrisk blanding, samt fremgangsmaate for fremstilling av blandingen
DE3574511D1 (de) Schaltung zur regelbaren vorspannungseinstellung und zur mikrowellenverbindung.
GR3007141T3 (de)
ES289145U (es) Cabeza de combate
Campbell Pollen-sedimentary environment relations and late holocene palynostratigraphy of the Ruby Range, Yukon Territory, Canada.
Reshef Foreign students socialization into sport
Garwe Moving beyond the BBC model: an analysis of the Zimbabwe Broadcasting Corporation.
HUT37408A (en) Process for the production of new 3-mercapto-1,2,4-triazole-derivatives
Morrogh Cast Iron--a Continuously Expanding Materials Group.--II
Novik et al. The Effect of Calcium on the Fracture Characteristics of Hot-Rolled Steel
FI902804A0 (fi) Foerfarande foer tillverkning av mjoelkprodukter.
GB9102931D0 (en) Improved means of regulating the temperature of an object by electrical means
FI872496A0 (fi) Foereningsanordning av isoleringar i byggnadselement.
Holmgren Analysis of the light curves of eclipsing variable stars
Cerquides Bueno An extension of the CM array for periodic power signals
Cleary What's It All about? The Critical Method of Analysis as Applied to Drama
AU7531287A (en) Substituted 1,2,3-thiadiazole-4-thiolates

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17P Request for examination filed

Effective date: 19930113

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950103